Common blood pressure drug raises skin cancer risk
A latest study proved by Danish-based researchers, shows that one of the most popular drugs used worldwide in the treatment of hypertension raises the risk of skin cancer by seven times.
The researchers were prompted in their endeavor by the fact that HCTZ has been linked with an increased risk of lip cancer in the past. In fact, a study led by Anton attributed 11 percent of lip cancer cases to the drug.
Moreover, HCTZ, the authors explain, makes the skin more sensitive to the damage of ultraviolet (UV) rays, due to its photo sensitizing effects. This was a further reason for the researchers to examine the drug.